# Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies

> **NCT02517281** · NA · COMPLETED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 141 (actual)

## Conditions studied

- Cancer

## Interventions

- **PROCEDURE:** Biopsy

## Key facts

- **NCT ID:** NCT02517281
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07-12
- **Primary completion:** 2022-06-22
- **Final completion:** 2022-06-22
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02517281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02517281, "Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02517281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*